Skip to main content
Registrieren
Springer Medizin Österreich
SUCHE
MENÜ 1 2 3 4
main-content
nach oben

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 1-2/2015

01.01.2015 | original article

Evaluation of liver perfusion in diabetic patients using 99mTc-sestamibi

verfasst von: Assist. Prof. Hacer Şen, Yusuf Ziya Tan, Emine Binnetoğlu, Mehmet Aşik, Fahri Güneş, Gökhan Erbağ, Emine Gazi, Sibel Cevizci, Semra Özdemir, Erdem Akbal, Kubilay Ükinç

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 1-2/2015

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Objective

The liver is an important organ for various aspects of glucose metabolism, including glucose uptake, storage, and synthesis. It is a major organ in the metabolic process with perfusion provided by both the portal vein and hepatic artery. In diabetic patients organ perfusion is reduced and this is linked to atherosclerosis, and as a result complications occur. In this study, we aimed to evaluate liver perfusion by scintigraphic methods in diabetic patients.

Design and patients

We retrospectively investigated 1,100 myocardial perfusion scintigraphies taken between January 2011 and December 2012 at Canakkale Onsekiz Mart University Medical Faculty Nuclear Medicine Department. A total of 66 patients who were diagnosed with diabetes mellitus and had myocardial perfusion scintigraphies were included in the study. The control subjects included 127 patients without diabetes mellitus who were chosen at random. Patients with chronic liver disease were not included in the study. The values from liver regions of interest (liver-ROI) rates and heart regions of interest (heart-ROI) rates were compared between the patients and controls.

Results

Patients were grouped according to the presence of diabetes. In the diabetes mellitus group, the liver-ROI average was lower (p = 0.66) than in the controls. In the control group, the average liver-ROI/heart-ROI ratios were higher than the ratio in the diabetes mellitus group (p = 0.019). Multivariate variance analysis showed that the diabetes mellitus liver-ROI/heart-ROI ratio was independent of other risk factors (p = 0.003; F: 9.6). Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation.

Conclusions

This study shows that liver perfusion in diabetic patients is reduced compared with those without diabetes. Prospective studies with larger patient groups are required.
Vorheriger Artikel A common disease but rare presentation: branchial cyst located on tonsil
Nächster Artikel No evidence for desmocollin 3 to serve as a prognostic marker in primary radiotherapy of head and neck cancer

Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:

Abo für kostenpflichtige Inhalte

Jetzt informieren
Literatur
1.
Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001;44(2):14–21.
2.
Naka KK, Papathanassiou K, Bechlioulis A, et al. Determinants of vascular function in patients with type 2 diabetes. Cardiovasc Diabetol. 2012;11:127.
3.
Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, patophysiology, and management. JAMA. 2002;287:2570–81.
4.
The Diabetes Control and Complications Trial research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.
5.
Schaefer WM, Moka D, Brockmann HA, Schomaecker K, Schicha H. Tl-201, Tc-99 m MIBI, Tc-99 m tetrofosmin and Tc-99 m furifosmin: relative retention and clearance kinetics in retrogradely perfused guinea pig hearts. Nucl Med Biol. 2002;29:243–54.
6.
Wackers FJ, Berman DS, Maddahi J, et al. Technetium-99 m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 myocardial perfusion imaging. J Nucl Med. 1989;30:301–11.
7.
Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond). 2005;109:143–59.
8.
Brownlee M, Viassara H, Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med. 1984;101:527–37.
9.
Krishnan B, Babu S, Walker J, Walker AB, Pappachan JM. Gastrointestinal complications of diabetes mellitus. World J Diabetes. 2013;4(3):51–63.
10.
Torbenson M, Chen YY, Brunt E, et al. Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus. Am J Surg Pathol. 2006;30:508–13.
11.
Mitra V, Metcalf J. Functional anatomy and blood supply of the liver, Anaesth. Intensive Care Med. 2009;10(7):332–3.
12.
Balci A, Karazincir S, Sumbas H, et al. Effects of diffuse fatty infiltration of the liver on portal vein flow hemodynamics. J Clin Ultrasound. 2008;36:134–40.
13.
Johnson DJ, Muhlbacher F, Wilmore DW. Measurement of hepatic blood flow. J Surg Res. 1985;39:470–81.
14.
Chundru S, Kalb B, Arif-Tiwari H, et al. MRI of diffuse liver disease: the common and uncommon etiologies. Diagn Interv Radiol. 2013;19(6):479–87.
15.
Rijzewijk LJ, van der Meer RW, Lubberink M, et al. Liver fat content in type 2 diabetes: relationship with hepatic perfusion and substrate metabolism. Diabetes. 2010;59(11):2747–54.
16.
Rausova Z, Chrenova J, Nuutila P, Iozzo P, Dedik L. System approach to modeling of liver glucose metabolism with physiologically interpreted model parameters outgoing from [18F]FDG concentrations measured by PET. Comput Methods Programs Biomed. 2012;107(2):347–56.
17.
Iozzo P, Jarvisalo MJ, Kiss J, et al. Quantification of liver glucose metabolism by positron emission tomography: validation study in pigs. Gastroenterology. 2007;132:531–42.
18.
Nuyts J, Dupont P, Van den Maegdenbergh V, et al. Study of the liver–heart artifact in emission tomography. J Nucl Med. 1995;36:133–9.
19.
Vitola JV, Brambatti JC, Caligaris F, et al. Exercise supplementation to dipyridamole prevents hypotension, improves electrocardiogram sensitivity, and increases heart-to-liver activity ratio on Tc-99 m sestamibi imaging. J Nucl Cardiol. 2001;8(6):652–9.
20.
Brock RW1, Dorman RB. Obesity, insulin resistance and hepatic perfusion. Microcirculation. 2007;14(4–5):339–47.
21.
Khimmaktong W, Petpiboolthai H, Panyarachun B, Anupunpisit V. Study of curcumin on microvasculature characteristic in diabetic rat’s liver as revealed by vascular corrosion cast/scanning electron microscope (SEM) technique. J Med Assoc Thai. 2012;95(5):133–41.
22.
Harrison SA, Brunt EM, Goodman ZD, Di Bisceglie AM. Diabetic hepatosclerosis: diabetic microangiopathy of the liver. Arch Pathol Lab Med. 2006;130(1):27–32.
Metadaten
Titel
Evaluation of liver perfusion in diabetic patients using 99mTc-sestamibi
verfasst von
Assist. Prof. Hacer Şen
Yusuf Ziya Tan
Emine Binnetoğlu
Mehmet Aşik
Fahri Güneş
Gökhan Erbağ
Emine Gazi
Sibel Cevizci
Semra Özdemir
Erdem Akbal
Kubilay Ükinç
Publikationsdatum
01.01.2015
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 1-2/2015
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-014-0614-5

Weitere Artikel der Ausgabe 1-2/2015

Wiener klinische Wochenschrift 1-2/2015 Zur Ausgabe

original article

No evidence for desmocollin 3 to serve as a prognostic marker in primary radiotherapy of head and neck cancer

review article

10th anniversary of the Austrian MDS Platform: aims and ongoing projects

images in clinical medicine

Trichobezoar causing recurrent gastric ulcer and perforation

original article

The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration

original article

Injury pattern in correlation with the height of fatal falls

case report

Spinal subdural hematoma following lumbar decompressive surgery: a report of two cases

Version: 0.1948.0